Clinical Trial Detail

NCT ID NCT02429843
Title A Study of TRC105 in Combination With Paclitaxel/Carboplatin and Bevacizumab in Non-Squamous Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Alabama at Birmingham
Indications

lung cancer

Therapies

Carboplatin + Paclitaxel

Bevacizumab

Carotuximab

Age Groups: adult

No variant requirements are available.